Literature DB >> 26014943

In Vitro Triple Combination of Antifungal Drugs against Clinical Scopulariopsis and Microascus Species.

Limin Yao1, Zhe Wan1, Ruoyu Li1, Jin Yu2.   

Abstract

Broth microdilution checkerboard techniques based on the methodology of the Clinical and Laboratory Standards Institute (CLSI) were employed to study the triple antifungal combination of caspofungin, posaconazole, and terbinafine against 27 clinical isolates of Scopulariopsis and Microascus species. Synergy was observed for 26 isolates, whereas antagonism was observed for Scopulariopsis candida in this study.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26014943      PMCID: PMC4505211          DOI: 10.1128/AAC.00145-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  31 in total

1.  Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial.

Authors:  Annemarie E Brouwer; Adul Rajanuwong; Wirongrong Chierakul; George E Griffin; Robert A Larsen; Nicholas J White; Thomas S Harrison
Journal:  Lancet       Date:  2004-05-29       Impact factor: 79.321

2.  Scopulariopsis brevicaulis abscess in a child treated for myeloblastic leukaemia.

Authors:  Arnaud Petit; Emmanuelle Levine; Ralph Epaud; Hubert Ducou Le Pointe; Adela Angoulvant
Journal:  Lancet Infect Dis       Date:  2011-05       Impact factor: 25.071

Review 3.  Overview of safety experience with caspofungin in clinical trials conducted over the first 15 years: a brief report.

Authors:  Angela L Ngai; Michael R Bourque; Robert J Lupinacci; Kim M Strohmaier; Nicholas A Kartsonis
Journal:  Int J Antimicrob Agents       Date:  2011-09-16       Impact factor: 5.283

4.  Phaeohyphomycosis due to Scopulariopsis brumptii in a liver transplant recipient.

Authors:  R Patel; C A Gustaferro; R A Krom; R H Wiesner; G D Roberts; C V Paya
Journal:  Clin Infect Dis       Date:  1994-07       Impact factor: 9.079

Review 5.  Pediatric invasive sinonasal Scopulariopsis brevicaulis--a case report and literature review.

Authors:  Ofer Gluck; Nili Segal; Fruchtman Yariv; Itzhack Polacheck; Max Puterman; David Greenberg; Benharroch Daniel
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2011-05-04       Impact factor: 1.675

6.  Onychomycosis in children: a survey of 46 cases.

Authors:  C Romano; M Papini; A Ghilardi; C Gianni
Journal:  Mycoses       Date:  2005-11       Impact factor: 4.377

7.  [In vitro antifungal activity of voriconazole against dermatophytes and superficial isolates of Scopulariopsis brevicaulis].

Authors:  Alfonso Javier Carrillo-Muñoz; Carmen Delia Cárdenes; Bartolomé Carrillo-Orive; Virginia Rodríguez; Osacr Del Valle; José Bou Casals; Pilar Ariadna Ezkurra; Guillermo Quindós
Journal:  Rev Iberoam Micol       Date:  2005-06       Impact factor: 1.044

8.  Antifungal interactions within the triple combination of amphotericin B, caspofungin and voriconazole against Aspergillus species.

Authors:  Elizabeth M O'Shaughnessy; Joseph Meletiadis; Theodouli Stergiopoulou; Joanne P Demchok; Thomas J Walsh
Journal:  J Antimicrob Chemother       Date:  2006-10-27       Impact factor: 5.790

Review 9.  Fatal Scopulariopsis brevicaulis infection in a paediatric stem-cell transplant patient treated with voriconazole and caspofungin and a review of Scopulariopsis infections in immunocompromised patients.

Authors:  W J Steinbach; W A Schell; J L Miller; J R Perfect; P L Martin
Journal:  J Infect       Date:  2004-01       Impact factor: 6.072

10.  In vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreus.

Authors:  Eric Dannaoui; Olivier Lortholary; Françoise Dromer
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

View more
  4 in total

1.  Invasive Scopulariopsis alboflavescens infection in patient with acute myeloid leukemia.

Authors:  Keiji Kurata; Sho Nishimura; Hiroya Ichikawa; Rina Sakai; Yu Mizutani; Kei Takenaka; Seiji Kakiuchi; Yoshiharu Miyata; Akihito Kitao; Kimikazu Yakushijin; Shinichiro Kawamoto; Katsuya Yamamoto; Mitsuhiro Ito; Hiroshi Matsuoka; Issei Tokimatsu; Katsuhiko Kamei; Hironobu Minami
Journal:  Int J Hematol       Date:  2018-07-09       Impact factor: 2.490

2.  Synergistic effects of vorinostat (SAHA) and azoles against Aspergillus species and their biofilms.

Authors:  Bo Tu; Gendi Yin; Hui Li
Journal:  BMC Microbiol       Date:  2020-02-07       Impact factor: 3.605

3.  Case Report: Successful Management of Refractory Keratomycosis in an Alpaca Using Penetrating Keratoplasty and Combination Antifungal Therapy (Caspofungin 0.5% and Terbinafine 1%).

Authors:  Braidee C Foote; Joe S Smith; Anna Catherine Bowden; Rachel A Allbaugh; Lionel Sebbag
Journal:  Front Vet Sci       Date:  2021-03-11

4.  Performance of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Scedosporium, Acremonium-Like, Scopulariopsis, and Microascus Species.

Authors:  Linwei Wei; Jin Shao; Yinggai Song; Zhe Wan; Limin Yao; Hong Wang; Jin Yu
Journal:  Front Microbiol       Date:  2022-03-02       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.